For most businesses, income arrives close to the point of sale. Community pharmacy does not work that way. Under the NHS contract, a pharmacy dispenses prescriptions throughout the month, submits a claim to NHS Business Services Authority (NHSBSA) the following month, and receives the balancing payment roughly two months after the original dispensing took place. An advance on account is paid earlier to help bridge the gap, but the underlying lag is a structural feature of the payment cycle, not an anomaly.
Understanding the FP34 cycle in detail is not a back-office concern. It determines how much working capital a pharmacy needs, how acquisition finance has to be structured, and why a rapidly growing dispensary can look profitable on paper while running short of cash in practice.
Note: The NHS contract arrangements described here apply in England. Scotland, Wales and Northern Ireland operate under separate contractual frameworks; content covering those jurisdictions will be published as a post-launch extension.
How the FP34 payment cycle works: the short answer
Community pharmacies in England submit their monthly prescription claims to NHSBSA using the FP34 process. Payment arrives roughly two months after the dispensing month, with an advance on account paid earlier in the cycle to smooth cash flow. Working-capital planning must model this NHSBSA lag: at any point in time, a pharmacy has two months of NHS income in transit between dispensing and full settlement.
What the FP34 is and why it matters
The FP34 is the monthly claim submission that turns a pharmacy's dispensing activity into NHS income. It covers prescriptions dispensed in the previous calendar month, itemising each item dispensed for reimbursement and remuneration under the Community Pharmacy Contractual Framework (CPCF).
This framing matters for how you read your accounts. Pharmacy income is contract-driven, not till-driven. The NHS does not pay you for what customers handed over at the counter. It reimburses you at Drug Tariff prices for the cost of drugs dispensed, then pays remuneration: the dispensing fee, the single activity fee, and any service payments earned (such as Pharmacy First fees). The total of those two streams, reimbursement plus remuneration, is your NHS income. Neither figure is a simple retail margin; both are set by a contract and processed through NHSBSA's payment system on its own timetable.
The FP34 is the submission that triggers that timetable each month.
The monthly submission step
At the end of each dispensing month, the pharmacy (or its dispensary management system) compiles the FP34 submission covering every NHS prescription item dispensed. The bundle is submitted to NHSBSA for pricing and verification. NHSBSA then processes the claim: checking item counts, applying current Drug Tariff prices, and calculating remuneration.
The submission is the start of the payment clock, not the end of it. From the moment the FP34 leaves the pharmacy, the business must wait for NHSBSA to complete its pricing and processing cycle before any payment is released.
When the money actually arrives: the payment lag and the advance on account
The full balancing payment from NHSBSA arrives roughly two months after the dispensing month. That two-month gap is not an error in the system; it reflects the time NHSBSA requires to price the submission and issue payment.
To reduce the cash pressure created by that lag, NHSBSA pays an advance on account earlier in the cycle. The advance is a partial payment made before the full balancing settlement, helping the pharmacy cover ongoing costs while the claim is being processed. It does not eliminate the lag. The remaining balance is settled when NHSBSA completes its pricing of the FP34 submission.
The practical result is that a pharmacy is always operating with a float tied up in the NHSBSA payment pipeline. For a stable business, that float is predictable. For a growing business, or one that has just changed hands, it is a live working-capital question.
An illustrative FP34 payment timeline
The table below shows how the cycle flows across a three-month window. Months, labels and descriptions are illustrative only; they are based on the NHSBSA submission and payment process and do not represent exact contractual payment dates for any specific pharmacy.
| Stage | Approximate timing | What happens |
|---|---|---|
| Dispensing month | Month 1 | Prescriptions dispensed throughout the month. No NHS cash received yet for this work. |
| FP34 submission | Early Month 2 | FP34 submitted to NHSBSA covering all Month 1 items. NHSBSA begins pricing and verification. |
| Advance on account | Month 2 | NHSBSA pays a partial advance to bridge the processing gap. This is an earlier payment, not the full settlement. |
| Balancing payment | Roughly Month 3 | Full settlement for Month 1 dispensing, after NHSBSA completes pricing. The advance is offset against the total due. |
Illustrative only. Actual payment timing depends on submission date, NHSBSA processing cycles and individual contract details. Use the FP34 cash-flow estimator to model the lag for your own dispensing volume.
Why the lag matters most when you grow or buy
For a pharmacy with stable dispensing volume, the FP34 lag is a known, manageable constant. The float tied up in the pipeline stays roughly the same from month to month, and the business can plan around it.
Two situations break that stability.
Growing dispensing volume. If your monthly prescription numbers are rising, the amount of NHS income sitting unpaid in the NHSBSA pipeline at any given moment is rising too. A pharmacy that doubles its items over twelve months will have roughly twice as much cash in transit at the end of that period compared to the start. Revenue on the profit and loss account grows; the cash in the bank does not keep pace. This mismatch is a classic working-capital squeeze in a contract business and it is one of the most common cash-flow surprises for owner-managers who look at their accounts rather than their payment cycle.
Buying a pharmacy. At the point of completion, the new owner takes over a dispensary that has been dispensing for weeks or months. The FP34 submissions covering that pre-completion work will generate advance payments and balancing payments that arrive after the acquisition completes. Depending on how completion is structured, those payments may belong partly or fully to the buyer, but they are payments for work done under the previous owner's operation. Modelling the cash-flow profile of the transition period is a material part of acquisition planning.
In both cases, the issue is the same: cash owed to the pharmacy grows faster than cash arriving at the pharmacy. Plugging that gap requires either a working-capital facility, careful management of stock and creditor timing, or both.
Planning your working capital around the cycle
The FP34 lag is fixed by the NHSBSA payment process; it cannot be shortened. What you can do is model it accurately so that stock purchases, payroll, loan repayments and owner drawings are timed around the payment cycle rather than against it.
The FP34 cash-flow estimator is designed for exactly this. Enter your monthly dispensing volume and it models the lag, showing how the advance and balancing payment flow against your ongoing outgoings. It is a scenario tool: it illustrates the shape of the cash-flow gap so you can plan the right level of working-capital buffer. It does not predict exact NHSBSA payment dates or amounts, which depend on Drug Tariff pricing at the time of payment.
Key planning questions the estimator helps you answer:
- How large a cash reserve does a pharmacy of my volume need to absorb the standard lag?
- If my dispensing volume grows by a given amount, how does the float in the pipeline change?
- How much additional working capital should an acquisition finance package include to cover the transition period?
These are not hypothetical questions. They are the basis on which lenders assess pharmacy acquisition finance and on which a well-run pharmacy owner manages monthly liquidity.
Reconciling what NHSBSA paid against what you expected
The advance on account and the balancing payment together should add up to the total due for the dispensing month. In practice, the settlement figure is not always what you assumed when you submitted the FP34.
Two reasons account for most variances. First, Drug Tariff prices and Category M reimbursement rates are set centrally and retrospectively adjusted. The price NHSBSA applies to an item at settlement may differ from the Drug Tariff price in force at the point of dispensing. Second, NHSBSA may query or adjust individual items during pricing. The net effect is that the payment schedule tells you what NHSBSA calculated, not what you expected.
Reconciling each monthly payment against your submission is therefore an essential accounting task, not a one-off check. Unreconciled variances accumulate and distort your income picture. A pharmacy that books NHSBSA income at its expected value rather than the settled value carries a balance sheet exposure that only surfaces when the reconciliation is done.
Our NHS payment reconciliation service covers this step: matching the NHSBSA payment schedule to your FP34 submission, identifying and explaining variances, and feeding the correct settled figures into your accounts. For pharmacies where Category M fluctuations are material, this reconciliation sits alongside margin analysis as a core monthly task. The Category M clawbacks explained guide covers the margin side in detail.
If you want to understand how your current dispensing volume translates into a cash-flow lag, start with the FP34 cash-flow estimator for a scenario view, then speak to us about building the full working-capital model for your pharmacy.